Hutch News

Hutch News

Stories tagged 'clinical research'

How new drugs become available to more patients

Filling in the unknowns on the balance between risk and benefit

Feb. 9, 2018 | by Susan Keown / Fred Hutch News Service

Often, new drugs are only approved to treat patients with advanced disease. But that can change as evidence accrues on the drugs’ risks and benefits.

View story >


New insights into CAR T-cell therapy's potential side effects

Detailed study of cytokine release syndrome and neurologic toxicities could help make emerging cancer immunotherapies safer

Dec. 11, 2017 | By Fred Hutch staff

Detailed studies of two potential side effects of an emerging cancer immunotherapy could eventually help make this strategy, CAR T-cell therapy, safer for patients. The studies examined cytokine release syndrome and neurologic toxicities.

View story >


Patients treated at cancer centers live longer: study

Finding of survival-rate differences between cancer hubs and community hospitals spurs call to ‘figure out the gaps’

Nov. 6, 2015 | By Bill Briggs / Fred Hutch News Service

Patients treated at one of 11 specialized cancer centers had higher survival rates compared to cancer patients treated at community hospitals, a study found.

View story >


‘Totally meant to be’

Why this Seattle teacher was motivated to serve the Fred Hutch high school intern program

Oct. 13, 2015 | By Megan Herndon / Fred Hutch News Service

Seattle teacher Kristin Storey's personal connection to cancer inspired her to help Fred Hutch high school interns last summer.

View story >


Good news at Fred Hutch

Dr. Peter Nelson principal researcher on prostate cancer 'Dream Team'; Dr. Kathi Malone honored by Komen Puget Sound; Dr. Eric Chow leads study of cardioprotective drug that addresses chemo concerns in children; and Dr. Linda Buck receives honorary doctorate from Harvard

May 28, 2015 | By Fred Hutch staff

Dr. Peter Nelson principal researcher on prostate cancer 'Dream Team'; Dr. Kathi Malone honored by Komen Puget Sound; Dr. Eric Chow leads study of cardioprotective drug that addresses chemo concerns in children; and Dr. Linda Buck receives honorary doctorate from Harvard.

View story >


Immunotherapy offers 'new era' for cancer patients

Dr. Stan Riddell wows Science for Life attendees with overview of one of the most promising areas of medical research

Feb. 20, 2015 | By Andrea Detter / Fred Hutch News Service

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.